Published in Ann Rheum Dis on March 01, 1992
Coexisting ankylosing spondylitis and gouty arthritis. Clin Rheumatol (2007) 0.76
Age at presentation with ankylosing spondylitis. Ann Rheum Dis (1992) 0.75
Monosodium urate crystal deposition associated with the progress of radiographic grade at the sacroiliac joint in axial SpA: a dual-energy CT study. Arthritis Res Ther (2017) 0.75
Ankylosing spondylitis--an analytical review of 1500 patients: the changing pattern of disease. J Rheumatol (1988) 3.29
The natural history of rheumatoid spondylitis. Medicine (Baltimore) (1956) 2.58
Is rheumatoid arthritis becoming less severe? J Chronic Dis (1983) 1.64
Ankylosing spondylitis in the Mexican mestizo: patterns of disease according to age at onset. J Rheumatol (1989) 1.08
Mycobacteria and rheumatoid arthritis. Arthritis Rheum (1990) 1.07
Role of enterobacteria and HLA-B27 in spondyloarthropathies: studies with transgenic mice. Ann Rheum Dis (1990) 0.95
[Ankylosing spondylarthritis with infantile and juvenile onset in Moracco]. Rev Rhum Mal Osteoartic (1973) 0.88
First two decades of British rheumatology: a personal perspective. Ann Rheum Dis (1990) 0.88
The changing epidemiology of rheumatic diseases: should ankylosing spondylitis now be included? Br J Rheumatol (1990) 0.87
The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum (1991) 11.66
A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol (1994) 11.17
Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol (1997) 5.09
Striking prevalence of ankylosing spondylitis in "healthy" w27 positive males and females. N Engl J Med (1975) 4.25
Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum (1997) 4.14
Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol (1994) 4.00
Clinical history as a screening test for ankylosing spondylitis. JAMA (1977) 3.60
Sex ratio in the spondyloarthropathies and its relationship to phenotypic expression, mode of inheritance and age at onset. J Rheumatol (1993) 3.39
The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology (2010) 3.36
Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis (1993) 2.78
Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. J Rheumatol (1999) 2.12
Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. J Rheumatol (1997) 2.11
The Portsmouth-based glaucoma refinement scheme: a role for virtual clinics in the future? Eye (Lond) (2012) 2.06
Bone loss as well as bone formation is a feature of progressive ankylosing spondylitis. Br J Rheumatol (1990) 2.03
Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum (1981) 1.97
The hand radiograph as a diagnostic discriminant between seropositive and seronegative 'rheumatoid arthritis': a controlled study. Ann Rheum Dis (1983) 1.96
Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis (2000) 1.92
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis (2002) 1.85
Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet (2001) 1.82
Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J Rheumatol (2001) 1.82
The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. Arthritis Rheum (1998) 1.80
HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis (1996) 1.79
An "experimental" epidemic of Reiter's syndrome revisited. Follow-up evidence on genetic and environmental factors. Ann Intern Med (1976) 1.74
The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol (1996) 1.73
Total hip arthroplasty in ankylosing spondylitis: outcome in 340 patients. J Rheumatol (2001) 1.71
Treatment of intractable rheumatoid arthritis with total lymphoid irradiation. N Engl J Med (1981) 1.69
Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug. Arthritis Rheum (2001) 1.68
Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev (2005) 1.65
The chronicity of symptoms and disability in Reiter's syndrome. An analysis of 131 consecutive patients. Ann Intern Med (1979) 1.53
Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration. Ann Oncol (2006) 1.49
A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI) J Rheumatol (1995) 1.49
Mechanical and constitutional risk factors for symptomatic knee osteoarthritis: differences between medial tibiofemoral and patellofemoral disease. J Rheumatol (1994) 1.48
A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum (1998) 1.41
The natural history of ankylosing spondylitis: is the disease really changing? J Rheumatol (1989) 1.40
Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet (1990) 1.39
Atypical antineutrophil cytoplasmic antibodies in patients with ankylosing spondylitis. Br J Rheumatol (1995) 1.38
Clinical assessment of osteoarthritis of the knee. Ann Rheum Dis (1990) 1.31
Energy expenditure during front crawl swimming: predicting success in middle-distance events. Int J Sports Med (1985) 1.30
Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. J Rheumatol (1999) 1.28
Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial. Rheumatology (Oxford) (1999) 1.28
Genetic differences between B27 positive patients with ankylosing spondylitis and B27 positive healthy controls. Arthritis Rheum (1983) 1.25
HLA-B27: to type of not to type? Ann Intern Med (1980) 1.23
Reiter's syndrome following epidemic shigellosis. J Rheumatol (1982) 1.23
Observer variation in grading sacroiliac radiographs in HLA-B27 positive individuals. J Rheumatol (1983) 1.23
Selective IgA deficiency and spondyloarthropathy: a distinct disease? Ann Rheum Dis (1990) 1.20
Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men. J Rheumatol (1990) 1.20
The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade). Rheumatology (Oxford) (2004) 1.17
Nine year follow-up study of morbidity and mortality in retinal vein occlusion. Eye (Lond) (2000) 1.15
Ankylosing spondylitis in women and men: a case-control study. J Rheumatol (1983) 1.15
The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis. Arthritis Rheum (1998) 1.14
Search for Reiter's syndrome after an outbreak of Shigella sonnei dysentery. J Rheumatol (1980) 1.13
A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression. Rheumatology (Oxford) (2007) 1.13
Is disease severity in ankylosing spondylitis genetically determined? Arthritis Rheum (2001) 1.10
Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group. Ann Rheum Dis (2003) 1.08
Development and validation of a self-efficacy scale for use in British patients with rheumatoid arthritis (RASE). Rheumatology (Oxford) (2001) 1.08
Non-B27 MHC associations of ankylosing spondylitis. Genes Immun (2006) 1.06
Ankylosing spondylitis: the correlation between a new metrology score and radiology. Br J Rheumatol (1995) 1.06
Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis. Hum Mol Genet (2000) 1.05
Minimal clinically important difference module: summary, recommendations, and research agenda. J Rheumatol (2001) 1.05
Socioeconomic status in ankylosing spondylitis: relationship between occupation and disease activity. J Rheumatol (1997) 1.04
Villoglandular adenocarcinoma of the cervix: clarity is needed on the histological definition for this difficult diagnosis. Gynecol Oncol (2005) 1.01
The development and validation of a radiographic grading system for the hip in ankylosing spondylitis: the bath ankylosing spondylitis radiology hip index. J Rheumatol (2000) 1.01
An update on the Bath Ankylosing Spondylitis Disease Activity and Functional Indices (BASDAI, BASFI): excellent Cronbach's alpha scores. J Rheumatol (1996) 0.99
The epidemiology of spondylodiscitis in ankylosing spondylitis--a controlled study. Br J Rheumatol (1996) 0.99
Ankylosing spondylitis. Clin Rheum Dis (1985) 0.99
New light on uveitis in ankylosing spondylitis. J Rheumatol (1991) 0.99
Double-bind cross-over tiral of flurbiprofen and phenylbutazone in ankylosing spondylitis. Br Med J (1974) 0.99
The prevalence and nature of back pain in an industrial complex: a questionnaire and radiographic and HLA analysis. Spine (Phila Pa 1976) (1980) 0.99
Fatigue in ankylosing spondylitis: its prevalence and relationship to disease activity, sleep, and other factors. J Rheumatol (1996) 0.97
Letter: "Ankylosing rheumatoid arthritis", ankylosing spondylitis, and HL-A antigens. Lancet (1974) 0.97
Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors. J Rheumatol (2001) 0.97
The natural history of ankylosing spondylitis. Does it burn out? J Rheumatol (1993) 0.97
Willingness to accept risk in the treatment of rheumatic disease. J Epidemiol Community Health (1990) 0.96
Aortitis in ankylosing spondylitis: early detection of aortic root abnormalities with two dimensional echocardiography. Am J Cardiol (1982) 0.94
Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis. A double-blind, randomized trial. Ann Intern Med (1985) 0.94
Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. Eur J Vasc Endovasc Surg (2006) 0.94
Ankylosing spondylitis sine sacroiliitis. Arthritis Rheum (1979) 0.93
Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix: a systematic review. Cancer Treat Rev (2004) 0.93
Presence of circulation immune complexes in Reiter's syndrome and ankylosing spondylitis. Clin Immunol Immunopathol (1981) 0.93
Bath Ankylosing Spondylitis Functional Index. Br J Rheumatol (1995) 0.92
Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis. Ann Rheum Dis (1994) 0.92
Peritoneal fluid concentrations of interleukin-8 in women with endometriosis: relationship to stage of disease. Hum Reprod (1998) 0.92
The X-chromosome and susceptibility to ankylosing spondylitis. Arthritis Rheum (2000) 0.92
Exercise in ankylosing spondylitis: how much is optimum? J Rheumatol (1998) 0.91
The case against seronegative rheumatoid arthritis. Am J Med (1981) 0.91
Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. J Rheumatol (1999) 0.91
Reference centile charts for measures of disease activity, functional impairment, and metrology in ankylosing spondylitis. Arthritis Rheum (1998) 0.90
Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Bull Rheum Dis (1982) 0.90
Radiographic osteoarthritis in the elderly population of Zagreb: distribution, correlates, and the pattern of joint involvement. Croat Med J (2000) 0.89
Late onset ankylosing spondylitis--a distinct disorder? Br J Rheumatol (1991) 0.88
The prevalence of chronic radiation enteritis following radiotherapy for cervical or endometrial cancer and its impact on quality of life. Eur J Oncol Nurs (2009) 0.88
The close correlation between symptoms and disease expression in HLA B27 positive individuals. J Rheumatol (1977) 0.88
Perception of prescription drug risks: a survey of patients with ankylosing spondylitis. J Rheumatol (1990) 0.88
The shape of the distal femur: a palaeopathological comparison of eburnated and non-eburnated femora. Ann Rheum Dis (1999) 0.88
Sustained improvement of intractable rheumatoid arthritis after total lymphoid irradiation. Arthritis Rheum (1983) 0.87
The localization of osteoarthritis. Br J Rheumatol (1994) 0.87
Reactive arthritis. Br Med J (1980) 0.87
The changing epidemiology of rheumatic diseases: should ankylosing spondylitis now be included? Br J Rheumatol (1990) 0.87
Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis. Ann Rheum Dis (1994) 0.87
Workshop III. Management of Reiter's syndrome. Ann Rheum Dis (1979) 0.86